Colostrum
Sponsors
Hadassah Medical Organization, Gangnam Severance Hospital, University of California, Davis, National Nutrition and Food Technology Institute, Parc de Salut Mar
Conditions
AnkyloglossiaChanges in the Oral MicrobiotaClostridium Difficile-Associated DiarrheaCritical IllnessGrowth FailureInfection ComplicationLeaky Gut SyndromeMicrobiota
Phase 2
Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies
WithdrawnNCT00747071
Start: 2011-09-30End: 2013-11-30Updated: 2012-08-28
Effect of Colostrum on Gut Permeability and Endotoxin Level in Chronic Alcoholic Disease
NCT01088087
Start: 2010-03-31End: 2010-12-31Target: 34Updated: 2010-03-17
Unknown Phase
Oral Administration of Colostrum to Premature Babies: Impact on the Oral Microbiota
CompletedNCT02306980
Start: 2013-10-31End: 2016-06-30Updated: 2017-07-25
A Trial of Enteral Colostrum on Clinical Outcomes in Critically Ill Patients
CompletedNCT03019250
Start: 2017-01-15End: 2018-11-07Updated: 2018-11-13
A Trial of Enteral Colostrum on Intestinal Permeability in Critically Ill Patients
CompletedNCT03186716
Start: 2017-06-11End: 2018-03-11Updated: 2018-04-17
Use of Inhaled Colostrum to Control Pain in Neonatal Frenotomy and Comparison to Inhaled Lavender Essential Oil
CompletedNCT06869902
Start: 2023-09-18End: 2024-06-30Updated: 2025-03-11
Impact of Colostrum Oropharyngeal Immunotherapy on Postnatal Growth in Preterm Infants
Not yet recruitingNCT07082881
Start: 2025-09-01End: 2028-09-30Target: 220Updated: 2025-07-24